Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Fsd Pharma Inc Cl B (HUGE)

2.1578   -0.052 (-2.36%) 02-25 11:24
Open: 2.24 Pre. Close: 2.21
High: 2.28 Low: 2.08
Volume: 622,095 Market Cap: 41M
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.283 - 2.296 2.296 - 2.308
Low: 2.068 - 2.084 2.084 - 2.098
Close: 2.186 - 2.21 2.21 - 2.232

Technical analysis

as of: 2021-02-25 11:12:41 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.00     One year: 5.19
Support: Support1: 1.78    Support2: 1.48
Resistance: Resistance1: 3.42    Resistance2: 4.44
Pivot: 2.56
Moving Average: MA(5): 2.22     MA(20): 2.43
MA(100): 1.97     MA(250): 2.84
MACD: MACD(12,26): 0.04     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 5.18     %D(3): 8.82
RSI: RSI(14): 45.41
52-week: High: 14.00  Low: 1.28  Change(%): -49.2
Average Vol(K): 3-Month: 271838  10-Days: 361001

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HUGE has closed above bottom band by 25.8%. Bollinger Bands are 135.8% wider than normal. The large width of the bands suggest high volatility as compared to HUGE's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Thu, 11 Feb 2021
FSD Pharma Announces US$20M At-The-Market Offering - Yahoo Finance

Wed, 10 Feb 2021
92 Biggest Movers From Yesterday - Benzinga

Wed, 27 Jan 2021
FSD Pharma Fires President, Certain Shareholders Look To Takeover Company - The Deep Dive

Tue, 26 Jan 2021
FSD Provides Corporate Update - Business Wire

Fri, 22 Jan 2021
FSD Pharma Sets Date for Annual Meeting - Business Wire

Thu, 12 Nov 2020
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update - Business Wire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 19
Shares Float (M) 16
% Held by Insiders 12.70
% Held by Institutions 0.73
Shares Short (K) 92
Shares Short P. Month (K) 74

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -46.2
Return on Equity (ttm) -105.0
Qtrly Rev. Growth
Gross Profit (p.s.) -0.174
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.